1. Simultaneous targeting of Eph receptors in glioblastoma
   Sara Ferluga et al, 2016, Oncotarget CrossRef
2. Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer
   Elena Andretta et al, 2017, Scientific Reports CrossRef
3. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway
   Juan Peng et al, 2016, Tumor Biology CrossRef
4. The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells
   Marianna Talia et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
5. A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets
   Zhe Cui et al, 2024, Frontiers in Oncology CrossRef
6. EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer
   Yong Wang et al, 2019, Digestive Diseases and Sciences CrossRef
7. Inhibiting Eph kinase activity may not be “Eph”ective for cancer treatment
   A. C. Herington et al, 2014, Growth Factors CrossRef
8. The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy
   Xiuzhi Duan et al, 2019, Journal of Clinical Laboratory Analysis CrossRef
9. EphA3 CAR T cells are effective against glioblastoma in preclinical models
   Paulo Martins et al, 2024, Journal for ImmunoTherapy of Cancer CrossRef
10. Loss of EphA3 Protein Expression Is Associated With Advanced TNM Stage in Clear-Cell Renal Cell Carcinoma
    Xiaolin Wang et al, 2017, Clinical Genitourinary Cancer CrossRef
11. Eph Receptors in Cancer
    Sakshi Arora et al, 2023, Biomedicines CrossRef
12. The Eph/Ephrin System in Hepatocellular Carcinoma: Functional Roles and Potential Therapeutic Targets
    Xin Shu et al, 2022, Oncologie CrossRef
13. The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer
    Xixun Zhang, 2021, Frontiers in Oncology CrossRef
14. High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival
    Baongoc Nasri et al, 2017, BMC Clinical Pathology CrossRef
15. In-silico predictions of deleterious SNPs in human ephrin type-A receptor 3 (EPHA3) gene
    Dipankor Chatterjee et al, 2021, Informatics in Medicine Unlocked CrossRef
16. A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer
    Peide Huang et al, 2021, Frontiers in Oncology CrossRef
17. A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity
    Nenad Tomasevic et al, 2014, Growth Factors CrossRef
18. EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells
    Francesco La Rocca et al, 2017, Cellular Oncology CrossRef
19. Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitors
    Nancy K. Gillis et al, 2017, Oncotarget CrossRef
20. EphA3 biology and cancer
    Peter W. Janes et al, 2014, Growth Factors CrossRef